.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Teva
Chubb
Mallinckrodt
Johnson and Johnson
Merck
Fuji
Express Scripts
Boehringer Ingelheim

Generated: June 28, 2017

DrugPatentWatch Database Preview

ZANTAC 300 Drug Profile

« Back to Dashboard

Which patents cover Zantac 300, and what generic Zantac 300 alternatives are available?

Zantac 300 is a drug marketed by Glaxo Grp Ltd and Glaxosmithkline and is included in two NDAs.

The generic ingredient in ZANTAC 300 is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty-one suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.

Summary for Tradename: ZANTAC 300

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list42
Clinical Trials: see list2,212
Patent Applications: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZANTAC 300 at DailyMed

Pharmacology for Tradename: ZANTAC 300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxo Grp Ltd
ZANTAC 300
ranitidine hydrochloride
TABLET;ORAL018703-002Dec 9, 1985ABRXYesYes► Subscribe► Subscribe
Glaxosmithkline
ZANTAC 300
ranitidine hydrochloride
CAPSULE;ORAL020095-002Mar 8, 1994DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZANTAC 300

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
ZANTAC 300
ranitidine hydrochloride
CAPSULE;ORAL020095-002Mar 8, 19944,128,658► Subscribe
Glaxosmithkline
ZANTAC 300
ranitidine hydrochloride
CAPSULE;ORAL020095-002Mar 8, 19945,028,432*PED► Subscribe
Glaxo Grp Ltd
ZANTAC 300
ranitidine hydrochloride
TABLET;ORAL018703-002Dec 9, 19854,128,658► Subscribe
Glaxo Grp Ltd
ZANTAC 300
ranitidine hydrochloride
TABLET;ORAL018703-002Dec 9, 19854,880,636*PED► Subscribe
Glaxosmithkline
ZANTAC 300
ranitidine hydrochloride
CAPSULE;ORAL020095-002Mar 8, 19944,521,431*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
UBS
Accenture
QuintilesIMS
Mallinckrodt
Moodys
AstraZeneca
Julphar
Colorcon
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot